Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 478

1.

Untreated adult GH deficiency is not associated with the development of metabolic risk factors: a long-term observational study.

Gasco V, Roncoroni L, Zavattaro M, Bona C, Berton A, Ghigo E, Maccario M, Grottoli S.

J Endocrinol Invest. 2019 Aug 22. doi: 10.1007/s40618-019-01100-y. [Epub ahead of print]

PMID:
31440920
2.

Cardiorespiratory fitness and muscular strength of deaf futsal players.

Favretto E, Fin W, Dos Santos Albarello JC, Halmenschlager GH, Bona CC, Pimentel GL, Calegari L.

J Exerc Rehabil. 2019 Jun 30;15(3):424-429. doi: 10.12965/jer.1836504.252. eCollection 2019 Jun.

3.

Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy.

Zamboni S, Foerster B, Abufaraj M, Seisen T, Roupret M, Colin P, De la Taille A, Di Bona C, Peyronnet B, Bensalah K, Herout R, Wirth MP, Novotny V, Soria F, Chlosta P, Antonelli A, Simeone C, Baumeister P, Mattei A, Montorsi F, Simone G, Gallucci M, Matsumoto K, Karakiewicz PI, Briganti A, Xylinas E, Shariat SF, Moschini M; Upper Tract Urothelial Carcinoma Collaboration Group; European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group.

BJU Int. 2019 Mar 25. doi: 10.1111/bju.14751. [Epub ahead of print]

PMID:
30908835
4.

Evaluation of Cause of Death After Radical Cystectomy for Patients With Bladder Cancer: The Impact of Age at the Time of Surgery.

Moschini M, Martini A, Zamboni S, Mattei A, Baumeister P, Di Bona C, Dell'Oglio P, Zaffuto E, Burgio G, Shariat SF, Sanchez-Salas R, Cathelineau X, Salonia A, Montorsi F, Briganti A, Gallina A, Colombo R.

Clin Genitourin Cancer. 2019 Jun;17(3):e541-e548. doi: 10.1016/j.clgc.2019.02.001. Epub 2019 Feb 13.

PMID:
30850337
5.

Contribution of Malaria to Inhospital Mortality in Papua New Guinean Children from a Malaria-Endemic Area: A Prospective Observational Study.

Laman M, Aipit S, Bona C, Aipit J, Davis TME, Manning L.

Am J Trop Med Hyg. 2019 Apr;100(4):835-841. doi: 10.4269/ajtmh.18-0769.

PMID:
30793683
6.

Radical Cystectomy in Pathological T4a and T4b Bladder Cancer Patients: Is There Any Space for Sub Stratification?

Moschini M, Zamboni S, Mattei A, Baumeister P, Di Bona C, Cornelius J, Shariat SF, Freschi M, Zaffuto E, Salonia A, Montorsi F, Briganti A, Colombo R, Gallina A; Ospedale San Raffaele.

Urol Int. 2019;102(3):269-276. doi: 10.1159/000493899. Epub 2019 Jan 29.

PMID:
30695782
7.

A Model for Trans-Kingdom Pathogenicity in Fonsecaea Agents of Human Chromoblastomycosis.

Fornari G, Gomes RR, Degenhardt-Goldbach J, Dos Santos SS, de Almeida SR, Dos Santos GD, Muro MD, Bona C, Scola RH, Trindade ES, Bini IH, Ferreira-Maba LS, Kestring DR, do Nascimento MMF, Lima BJFS, Voidaleski MF, Steinmacher DA, Soley BDS, Deng S, Bocca AL, da Silva MB, Salgado CG, de Azevedo CMPES, Vicente VA, de Hoog S.

Front Microbiol. 2018 Oct 9;9:2211. doi: 10.3389/fmicb.2018.02211. eCollection 2018.

8.

Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e.

Franco P, Arcadipane F, Trino E, Gallio E, Martini S, Iorio GC, Piva C, Moretto F, Ruo Redda MG, Verna R, Tseroni V, Bona C, Pozzi G, Fiandra C, Ragona R, Bertetto O, Ricardi U.

Clin Transl Radiat Oncol. 2018 Jun 11;11:33-39. doi: 10.1016/j.ctro.2018.06.002. eCollection 2018 Jun.

9.

80-W GreenLight Laser Vaporization Versus Transurethral Resection of the Prostate for Treatment of Benign Prostatic Obstruction: 5-Year Outcomes of a Single-center Prospective Randomized Trial.

Mordasini L, Di Bona C, Klein J, Mattei A, Wirth GJ, Iselin CE.

Urology. 2018 Jun;116:144-149. doi: 10.1016/j.urology.2018.01.037. Epub 2018 Feb 12.

PMID:
29447947
10.

Development of Canavalia ensiformis in soil contaminated with diesel oil.

Balliana AG, Moura BB, Inckot RC, Bona C.

Environ Sci Pollut Res Int. 2017 Jan;24(1):979-986. doi: 10.1007/s11356-016-7674-1. Epub 2016 Oct 20.

PMID:
27761870
11.

Retrospective observational analysis of non-irradiated non-functioning pituitary adenomas.

Karamouzis I, Berardelli R, Prencipe N, Berton A, Bona C, Stura G, Corsico M, Gasco V, Maccario M, Ghigo E, Grottoli S.

J Endocrinol Invest. 2015 Nov;38(11):1191-7. doi: 10.1007/s40618-015-0361-0. Epub 2015 Jul 28.

PMID:
26215449
12.

Ultrasonographic assessment of splenic volume at presentation and after anti-malarial therapy in children with malarial anaemia.

Laman M, Aipit S, Bona C, Siba PM, Robinson LJ, Manning L, Davis TM.

Malar J. 2015 May 28;14:219. doi: 10.1186/s12936-015-0741-0.

13.

Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial.

Laman M, Moore BR, Benjamin JM, Yadi G, Bona C, Warrel J, Kattenberg JH, Koleala T, Manning L, Kasian B, Robinson LJ, Sambale N, Lorry L, Karl S, Davis WA, Rosanas-Urgell A, Mueller I, Siba PM, Betuela I, Davis TM.

PLoS Med. 2014 Dec 30;11(12):e1001773. doi: 10.1371/journal.pmed.1001773. eCollection 2014 Dec.

14.

Viral pathogens in children hospitalized with features of central nervous system infection in a malaria-endemic region of Papua New Guinea.

Laman M, Hwaiwhanje I, Bona C, Warrel J, Aipit S, Smith D, Noronha J, Siba P, Mueller I, Betuela I, Davis TM, Manning L.

BMC Infect Dis. 2014 Nov 26;14:630. doi: 10.1186/s12879-014-0630-0.

15.

Accuracy of initial clinical diagnosis of acute bacterial meningitis in children from a malaria-endemic area of Papua New Guinea.

Aipit J, Laman M, Hwaiwhanje I, Bona C, Pomat N, Siba P, Davis TM, Manning L.

Trans R Soc Trop Med Hyg. 2014 Jul;108(7):444-8. doi: 10.1093/trstmh/tru067. Epub 2014 May 3.

PMID:
24794922
16.

FDA's nozzle numerical simulation challenge: non-Newtonian fluid effects and blood damage.

Trias M, Arbona A, Massó J, Miñano B, Bona C.

PLoS One. 2014 Mar 25;9(3):e92638. doi: 10.1371/journal.pone.0092638. eCollection 2014.

17.

Severe anemia in Papua New Guinean children from a malaria-endemic area: a case-control etiologic study.

Manning L, Laman M, Rosanas-Urgell A, Michon P, Aipit S, Bona C, Siba P, Mueller I, Davis TM.

PLoS Negl Trop Dis. 2012;6(12):e1972. doi: 10.1371/journal.pntd.0001972. Epub 2012 Dec 13.

18.

Rapid antigen detection tests for malaria diagnosis in severely ill Papua New Guinean children: a comparative study using Bayesian latent class models.

Manning L, Laman M, Rosanas-Urgell A, Turlach B, Aipit S, Bona C, Warrell J, Siba P, Mueller I, Davis TM.

PLoS One. 2012;7(11):e48701. doi: 10.1371/journal.pone.0048701. Epub 2012 Nov 5.

19.

Mesenchymal stem cells from patients to assay bone graft substitutes.

Manfrini M, Di Bona C, Canella A, Lucarelli E, Pellati A, D'Agostino A, Barbanti-Bròdano G, Tognon M.

J Cell Physiol. 2013 Jun;228(6):1229-37. doi: 10.1002/jcp.24276. Erratum in: J Cell Physiol. 2013 Oct;228(10):2095-6.

PMID:
23129455
20.

A relevant long-term impact of the circulation of a potentially contaminated vaccine on the distribution of scrapie in Italy. Results from a retrospective cohort study.

Bertolini S, Maurella C, Bona C, Ingravalle F, Desiato R, Baioni E, Chiavacci L, Caramelli M, Ru G.

Vet Res. 2012 Aug 28;43:63. doi: 10.1186/1297-9716-43-63.

21.

Features and prognosis of severe malaria caused by Plasmodium falciparum, Plasmodium vivax and mixed Plasmodium species in Papua New Guinean children.

Manning L, Laman M, Law I, Bona C, Aipit S, Teine D, Warrell J, Rosanas-Urgell A, Lin E, Kiniboro B, Vince J, Hwaiwhanje I, Karunajeewa H, Michon P, Siba P, Mueller I, Davis TM.

PLoS One. 2011;6(12):e29203. doi: 10.1371/journal.pone.0029203. Epub 2011 Dec 22.

22.

The 2011 Nobel Prize--honoring the memory of Dr. Ralph Steinman.

Bona C, Bot A.

Int Rev Immunol. 2011 Oct-Dec;30(5-6):233-4. doi: 10.3109/08830185.2011.630972. No abstract available.

PMID:
22053967
23.

Dimeric MHC-peptides inserted into an immunoglobulin scaffold as new immunotherapeutic agents.

Goldberg B, Bona C.

J Cell Mol Med. 2011 Sep;15(9):1822-32. doi: 10.1111/j.1582-4934.2011.01319.x. Review.

24.

Plasma Plasmodium falciparum histidine-rich protein-2 concentrations do not reflect severity of malaria in Papua new guinean children.

Manning L, Laman M, Stanisic D, Rosanas-Urgell A, Bona C, Teine D, Siba P, Mueller I, Davis TM.

Clin Infect Dis. 2011 Feb 15;52(4):440-6. doi: 10.1093/cid/ciq105. Epub 2011 Jan 7.

PMID:
21216895
25.
26.

Double negative (CD3+ 4- 8-) TCR alphabeta splenic cells from young NOD mice provide long-lasting protection against type 1 diabetes.

Duncan B, Nazarov-Stoica C, Surls J, Kehl M, Bona C, Casares S, Brumeanu TD.

PLoS One. 2010 Jul 2;5(7):e11427. doi: 10.1371/journal.pone.0011427.

27.

Reversal of type 1 diabetes by a new MHC II-peptide chimera: "Single-epitope-mediated suppression" to stabilize a polyclonal autoimmune T-cell process.

Lin M, Stoica-Nazarov C, Surls J, Kehl M, Bona C, Olsen C, Brumeanu TD, Casares S.

Eur J Immunol. 2010 Aug;40(8):2277-88. doi: 10.1002/eji.200940094.

28.

Release of developmental constraints on tetrad shape is confirmed in inaperturate pollen of Potamogeton.

Nunes EL, Bona C, Moço MC, Coan AI.

Ann Bot. 2009 Oct;104(5):1011-5. doi: 10.1093/aob/mcp160. Epub 2009 Jun 30.

29.

CD28 signaling in T regulatory precursors requires p56lck and rafts integrity to stabilize the Foxp3 message.

Nazarov-Stoica C, Surls J, Bona C, Casares S, Brumeanu TD.

J Immunol. 2009 Jan 1;182(1):102-10.

30.
31.

Histidine at codon 154 of the prion protein gene is a risk factor for Nor98 scrapie in goats.

Colussi S, Vaccari G, Maurella C, Bona C, Lorenzetti R, Troiano P, Casalinuovo F, Di Sarno A, Maniaci MG, Zuccon F, Nonno R, Casalone C, Mazza M, Ru G, Caramelli M, Agrimi U, Acutis PL.

J Gen Virol. 2008 Dec;89(Pt 12):3173-6. doi: 10.1099/vir.0.2008/004150-0.

PMID:
19008408
32.

A peptide-major histocompatibility complex II chimera favors survival of pancreatic beta-islets grafted in type 1 diabetic mice.

Casares S, Lin M, Zhang N, Teijaro JR, Stoica C, McEvoy R, Farber DL, Bona C, Brumeanu TD.

Transplantation. 2008 Jun 27;85(12):1717-25. doi: 10.1097/TP.0b013e31817752cc.

PMID:
18580462
33.

Comparison of endorectal magnetic resonance imaging, clinical prognostic factors and nomograms in the local staging of prostate cancer patients treated with radiotherapy.

Cirillo S, Petracchini M, Bona CM, Durando S, Ortega C, Vormola R, Stasi M, Malinverni G, Aglietta M, Regge D, Gabriele P.

Tumori. 2008 Jan-Feb;94(1):65-9.

PMID:
18468337
34.

Natural antibody--complement dependent neutralization of bovine herpesvirus 4 by human serum.

Machiels B, Gillet L, Nascimento Brito SD, Drion P, Delforge C, Nizet Y, Gianello P, Bona C, Costes B, Markine-Goriaynoff N, Vanderplasschen A.

Microbes Infect. 2007 Nov-Dec;9(14-15):1530-7. Epub 2007 Aug 31.

PMID:
18024120
35.

Are quality indicators for radiotherapy useful in the evaluation of service efficacy in a new based radiotherapy institution?

Gabriele P, Malinverni G, Bona C, Manfredi M, Delmastro E, Gatti M, Penduzzu G, Baiotto B, Stasi M.

Tumori. 2006 Nov-Dec;92(6):496-502.

PMID:
17260490
37.

[Use of discharge records to define the oncological diagnoses for outpatient radiotherapy patients].

Pagano E, Di Cuonzo D, Bona C, Baldi I, Segnan N, Merletti F, Ciccone G.

Epidemiol Prev. 2006 Mar-Apr;30(2):132-8. Italian.

38.

Assessment of clinical criteria to diagnose scrapie in Italy.

D'Angelo A, Maurella C, Bona C, Borrelli A, Caramelli M, Elena Careddu M, Jaggy A, Ru G.

Vet J. 2007 Jul;174(1):106-12. Epub 2006 Aug 1.

PMID:
16884935
39.
40.

Viscosity as an inseparable partner of muscle contraction.

Grazi E, Di Bona C.

J Theor Biol. 2006 Oct 21;242(4):853-61. Epub 2006 Jun 3.

PMID:
16844144
41.

Accessibility as a major determinant of radiotherapy underutilization: a population based study.

Pagano E, Di Cuonzo D, Bona C, Baldi I, Gabriele P, Ricardi U, Rotta P, Bertetto O, Appiano S, Merletti F, Segnan N, Ciccone G.

Health Policy. 2007 Mar;80(3):483-91. Epub 2006 Jun 14.

PMID:
16781002
42.

Differential partitioning and trafficking of GM gangliosides and cholesterol-rich lipid rafts in thymic and splenic CD4 T cells.

Brumeanu TD, Preda-Pais A, Stoica C, Bona C, Casares S.

Mol Immunol. 2007 Jan;44(4):530-40. Epub 2006 Apr 4.

PMID:
16597465
43.
44.

Molecular aspects of regulation of collagen gene expression in fibrosis.

Bhogal RK, Stoica CM, McGaha TL, Bona CA.

J Clin Immunol. 2005 Nov;25(6):592-603. Review.

PMID:
16380822
45.

Recombinant immunoglobulin-based epitope delivery: a novel class of autoimmune regulators.

Phillips WJ, Smith DJ, Bona CA, Bot A, Zaghouani H.

Int Rev Immunol. 2005 Sep-Dec;24(5-6):501-17. Review.

PMID:
16318992
46.

B cells: no longer bystanders in liver fibrosis.

Bhogal RK, Bona CA.

J Clin Invest. 2005 Nov;115(11):2962-5.

47.
48.

Short communication: Pasteurization of milk abolishes bovine herpesvirus 4 infectivity.

Bona C, Dewals B, Wiggers L, Coudijzer K, Vanderplasschen A, Gillet L.

J Dairy Sci. 2005 Sep;88(9):3079-83.

49.

Soluble, dimeric HLA DR4-peptide chimeras: an approach for detection and immunoregulation of human type-1 diabetes.

Preda I, McEvoy RC, Lin M, Bona CA, Rapaport R, Brumeanu TD, Casares S.

Eur J Immunol. 2005 Sep;35(9):2762-75.

50.

Cooperative behaviour of the elementary sarcomere units and the cross-bridge step size.

Grazi E, Di Bona C.

Biophys Chem. 2005 Dec 1;118(2-3):113-7. Epub 2005 Aug 15.

PMID:
16099091

Supplemental Content

Support Center